A novel antibiotic combination of linezolid and polymyxin B octapeptide PBOP against clinical Pseudomonas aeruginosa strains

BACKGROUND: Antibiotic-resistant Gram-negative bacteria are becoming a major public health threat such as the important opportunistic pathogen Pseudomonas aeruginosa (P. aeruginosa). The present study investigated enhancement of the linezolid spectrum, which is normally used to treat Gram-positive b...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ting, Zeng, Mao, Fu, Huiyao, Zhao, Kelei, Song, Tao, Guo, Yidong, Zhou, Jingyu, Zhai, Longfei, Liu, Chaolan, Prithiviraj, Balakrishnan, Wang, Xinrong, Chu, Yiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422153/
https://www.ncbi.nlm.nih.gov/pubmed/36038932
http://dx.doi.org/10.1186/s12941-022-00531-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422153/
https://www.ncbi.nlm.nih.gov/pubmed/36038932
http://dx.doi.org/10.1186/s12941-022-00531-5

Ejemplares similares